WisdomTree BioRevolution Fund
Price through Nov 16, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
WDNA price
Table
| Date | WDNA close |
|---|---|
| Aug 17, 2026 | $21.45 |
| Aug 18, 2026 | $21.38 |
| Aug 19, 2026 | $23.99 |
| Aug 20, 2026 | $23.20 |
| Aug 21, 2026 | $23.66 |
| Aug 24, 2026 | $23.24 |
| Aug 25, 2026 | $24.07 |
| Aug 26, 2026 | $23.90 |
| Aug 27, 2026 | $23.84 |
| Aug 28, 2026 | $23.19 |
| Aug 31, 2026 | $23.15 |
| Sep 1, 2026 | $23.22 |
| Sep 2, 2026 | $23.47 |
| Sep 3, 2026 | $23.43 |
| Sep 4, 2026 | $23.08 |
| Sep 8, 2026 | $22.73 |
| Sep 9, 2026 | $22.47 |
| Sep 10, 2026 | $22.11 |
| Sep 11, 2026 | $22.14 |
| Sep 14, 2026 | $22.46 |
| Sep 15, 2026 | $22.30 |
| Sep 16, 2026 | $22.27 |
| Sep 17, 2026 | $23.29 |
| Sep 18, 2026 | $23.09 |
| Sep 21, 2026 | $23.43 |
| Sep 22, 2026 | $23.92 |
| Sep 23, 2026 | $23.23 |
| Sep 24, 2026 | $23.95 |
| Sep 25, 2026 | $23.93 |
| Sep 28, 2026 | $23.95 |
| Sep 29, 2026 | $24.13 |
| Sep 30, 2026 | $24.10 |
| Oct 1, 2026 | $23.63 |
| Oct 2, 2026 | $23.68 |
| Oct 5, 2026 | $24.31 |
| Oct 6, 2026 | $22.93 |
| Oct 7, 2026 | $22.79 |
| Oct 8, 2026 | $22.60 |
| Oct 9, 2026 | $23.50 |
| Oct 12, 2026 | $23.01 |
| Oct 13, 2026 | $22.67 |
| Oct 14, 2026 | $22.80 |
| Oct 15, 2026 | $23.21 |
| Oct 16, 2026 | $22.30 |
| Oct 19, 2026 | $22.69 |
| Oct 20, 2026 | $23.37 |
| Oct 21, 2026 | $23.52 |
| Oct 22, 2026 | $23.18 |
| Oct 23, 2026 | $23.04 |
| Oct 26, 2026 | $23.18 |
| Oct 27, 2026 | $23.96 |
| Oct 28, 2026 | $24.61 |
| Oct 29, 2026 | $24.67 |
| Oct 30, 2026 | $24.11 |
| Nov 2, 2026 | $23.61 |
| Nov 3, 2026 | $23.89 |
| Nov 4, 2026 | $24.28 |
| Nov 5, 2026 | $22.77 |
| Nov 6, 2026 | $23.09 |
| Nov 9, 2026 | $23.91 |
| Nov 10, 2026 | $23.48 |
| Nov 11, 2026 | $23.57 |
| Nov 12, 2026 | $22.79 |
| Nov 13, 2026 | $22.57 |
| Nov 16, 2026 | $21.84 |
Recent fund-flow records are unavailable, while the price has returned +29.4% so far this year. At 0.45% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 3.64% | $1431.67 | -0.8% | ||
| 2 | TEMTEMPUS AI INC | 3.74% | $64.76 | -9.6% | ||
| 3 | MRNAMODERNA | 3.38% | $215.27 | -3.6% | ||
| 4 | IMNMIMMUNOME | 2.92% | $17.61 | -6.2% | ||
| 5 | TWSTTWIST BIOSCIENCE | 3.00% | $105.04 | -5.9% | ||
| 6 | TMOTHERMO FISHER SCIENTIFIC | 2.56% | $691.33 | -1.3% | ||
| 7 | STOKSTOKE THERAPEUTICS | 2.33% | $26.63 | -0.2% | ||
| 8 | UTHRUNITED THERAPEUTICS | 2.14% | $587.88 | -0.6% | ||
| 9 | NTRANATERA | 2.38% | $288.48 | -9.6% | ||
| 10 | CGONCG ONCOLOGY INC | 1.78% | $84.78 | +14.0% | ||
| 11 | VRTXVERTEX PHARMACEUTICALS | 1.90% | $537.79 | -0.2% | ||
| 12 | AMGNAMGEN | 1.81% | $462.32 | -0.7% | ||
| 13 | GILDGILEAD SCIENCES | 1.81% | $167.58 | -0.3% | ||
| 14 | TXG10X GENOMICS | 1.92% | $54.99 | -5.5% | ||
| 15 | ROIVROIVANT SCIENCES | 1.75% | $38.61 | -2.3% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 99Sector weights
- Healthcare93.1%
- Health Technology80.24%
- Process Industries11.92%
- Other4.81%
- Basic Materials3.55%
- Health Services3.18%
- Consumer Non-Durables2.58%
- 2.49%
- Consumer Defensive1.77%
- Financial Services1.58%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 93.1% |
| Health Technology | 80.24% |
| Process Industries | 11.92% |
| Other | 4.81% |
| Basic Materials | 3.55% |
| Health Services | 3.18% |
| Consumer Non-Durables | 2.58% |
| 2.49% | |
| Consumer Defensive | 1.77% |
| Financial Services | 1.58% |
Country weights
- United States86.3%
- Other5.19%
- United Kingdom4.62%
- Switzerland2.59%
- Germany2.09%
- Denmark2.04%
- Japan1.4%
- Netherlands1.18%
Show as table
| Item | Value (%) |
|---|---|
| United States | 86.3% |
| Other | 5.19% |
| United Kingdom | 4.62% |
| Switzerland | 2.59% |
| Germany | 2.09% |
| Denmark | 2.04% |
| Japan | 1.4% |
| Netherlands | 1.18% |
| 1 week | -7.0% |
| 1 month | -2.1% |
| 3 months | +3.4% |
| 6 months | +26.4% |
| YTD | +29.4% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 3.7% of the book; the top ten carry 28%. Spread across 83+ names, it behaves like roughly 60 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $45M |
| MRNA MODERNA | $30M | $26M |
| NTRA NATERA | $20M | $1M |
| MRK MERCK & CO | $6M | $5M |
| CGON CG ONCOLOGY INC | $3M | $6M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat WDNA on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -42bp on fee · 16431× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -42bp on fee · 7240× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -40bp on fee · 48808× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -41bp on fee · 13417× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -41bp on fee · 9365× the assets · +$422M in over the month | Head-to-head |


